Mancini Marianna bought VKTX

January 2, 2026 · Form 4 insider transaction

Mancini Marianna bought 32,049 shares of Viking Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.

Direction
Acquired (buy-side)
Shares
32,049
Price
$0.00
Total value
N/A
RoleOfficer
SecurityCommon Stock, par value $0.00001 per share
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2026
Filing dateJanuary 5, 2026
Shares owned after466,851
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2023, 33.33% of which vested on January 2, 2026, upon the achievement of a non-financial performance goal and a second performance restricted stock unit award that was granted on January 3, 2025, 1.665% of which vested on January 2, 2026, upon the partial achievement of a non-financial performance goal.

View the original Form 4 on SEC EDGAR